Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 54:67-77, doi:10.1016/j.jacc.2009.04.016
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Keogh, A. M.
Right arrow Articles by Sandoval, J.
PubMed
Right arrow Articles by Keogh, A. M.
Right arrow Articles by Sandoval, J.

STATE-OF-THE-ART PAPER

Interventional and Surgical Modalities of Treatment in Pulmonary Hypertension

Anne M. Keogh, MBBS, PhD*,*, Eckhard Mayer, MD{dagger}, Raymond L. Benza, MD{ddagger}, Paul Corris, MD§, Philippe G. Dartevelle, MD||, Adaani E. Frost, MD, Nick H. Kim, MD#, Irene M. Lang, MD**, Joanna Pepke-Zaba, PhD{dagger}{dagger} and Julio Sandoval, MD{ddagger}{ddagger}

* St. Vincent's Hospital, Sydney, Australia
{dagger} Catholic Academic Hospital, Mainz, Germany
{ddagger} Drexel University College of Medicine, Allegheny General Hospital, Pittsburgh, Pennsylvania
§ Freeman Hospital, Newcastle upon Tyne, United Kingdom
|| Marie Lannelongue Hospital, Le Plessis Robinson, France
Baylor College of Medicine, Houston, Texas
# University of California, San Diego, School of Medicine, La Jolla, California
** Medical University of Vienna, Vienna, Austria
{dagger}{dagger} Papworth Hospital, Papworth Everard, Cambridge, United Kingdom
{ddagger}{ddagger} National Institute of Cardiology, Mexico City, Mexico

Manuscript received April 13, 2009; accepted April 15, 2009.

* Reprint requests and correspondence: Prof. Anne M. Keogh, St. Vincent's Hospital, Victoria Street, Darlinghurst 2010, Sydney NSW, Australia (Email: amkeogh{at}stvincents.com.au).

Most patients with chronic thromboembolic pulmonary hypertension are operable, and pulmonary endarterectomy is the treatment of choice. Pulmonary endarterectomy should not be delayed for medical therapy, and risk stratification helps to define patients likely to achieve the best outcome. Inoperable patients should be referred for trials of medical agents. Atrial septostomy is promising but underutilized, although better ways of ensuring an adequate, lasting septostomy still need to be determined. Indications for the procedure are unchanged, and it should be considered more frequently. Bilateral sequential lung or heart–lung transplantation is an important option for selected patients, and potential candidates who are class IV or III but not improving should be referred early to a transplantation center. Currently, there is a need for right ventricular assist devices with flow characteristics suited to the circulation of patients with pulmonary arterial hypertension. Right ventricular synchronization therapy has not yet been tested. Novel shunts (e.g., Potts anastomosis) also hold promise. All surgery for pulmonary hypertension should be performed in centers with experience in these techniques.

Key Words: surgical modalities • treatment in PAH • interventional modalities

Abbreviations and Acronyms
  AS = atrial septostomy
  BLTx = bilateral lung transplantation
  CI = cardiac index
  CO = cardiac output
  CTEPH = chronic thromboembolic pulmonary hypertension
  DHCA = deep hypothermic circulatory arrest
  ECLS = extracorporeal life support
  ECMO = extracorporeal membrane oxygenation
  HLTx = heart–lung transplantation
  IPAH = idiopathic pulmonary arterial hypertension
  IVC = inferior vena cava
  LV = left ventricle/ventricular
  mPAP = mean pulmonary arterial pressure
  mRAP = mean right atrial pressure
  NYHA = New York Heart Association
  PAH = pulmonary arterial hypertension
  PEA = pulmonary endarterectomy
  PH = pulmonary hypertension
  PVR = pulmonary vascular resistance
  RAP = right atrial pressure
  RV = right ventricular
  6MWD = six-min walk distance
  SOT = systemic arterial oxygen saturation




This article has been cited by other articles:


Home page
Eur Heart JHome page
Authors/Task Force Members, N. Galie, M. M. Hoeper, M. Humbert, A. Torbicki, J.-L. Vachiery, J. A. Barbera, M. Beghetti, P. Corris, S. Gaine, et al.
Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
Eur. Heart J., October 2, 2009; 30(20): 2493 - 2537.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. J. Barst, J. S. R. Gibbs, H. A. Ghofrani, M. M. Hoeper, V. V. McLaughlin, L. J. Rubin, O. Sitbon, V. F. Tapson, and N. Galie
Updated evidence-based treatment algorithm in pulmonary arterial hypertension.
J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S78 - S84.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. M. Hoeper, J. A. Barbera, R. N. Channick, P. M. Hassoun, I. M. Lang, A. Manes, F. J. Martinez, R. Naeije, H. Olschewski, J. Pepke-Zaba, et al.
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension.
J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S85 - S96.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement